搜索结果: 1-15 共查到“医学 colorectal cancer”相关记录40条 . 查询时间(0.055 秒)
Vitamin B-6 and colorectal cancer risk: a prospective population-based study using 3 distinct plasma markers of vitamin B-6 status
biomarkers colorectal cancer inflammation metabolite ratios vitamin B-6
2018/11/13
Background: Higher plasma concentrations of the vitamin B-6 marker pyridoxal 5′-phosphate (PLP) have been associated with reduced colorectal cancer (CRC) risk. Inflammatory processes, including vitami...
Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer
colorectal neoplasms body composition body weight changes prognosis recurrence
2018/12/14
Background: Studies on the association between body mass index (BMI) and colorectal cancer (CRC) prognosis after diagnosis have yielded inconsistent results. Few studies have investigated associations...
Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer
colorectal neoplasms body composition body weight changes prognosis recurrence
2018/12/18
Background: Studies on the association between body mass index (BMI) and colorectal cancer (CRC) prognosis after diagnosis have yielded inconsistent results. Few studies have investigated associations...
Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany
colorectal neoplasms alcohol consumption survival prognosis recurrence
2018/11/30
Background: Studies on the association between alcohol consumption and colorectal cancer (CRC) prognosis have yielded inconsistent results.
Racial differences in dietary changes and quality of life after a colorectal cancer diagnosis: a follow-up of the Study of Outcomes in Colorectal Cancer Survivors cohort
race diet quality of life colorectal cancer survivors
2018/11/30
Background: Substantial racial disparities exist in colorectal cancer (CRC) survival.
Objective: This was an exploratory study to assess the racial differences in dietary changes in relation to quali...
Prognostic Significance of Nuclear β-Catenin Expression in Patients with Colorectal Cancer from Iran
Beta Catenin Colorectal Cancer Prognostic Biomarkers Neoplasm Staging
2015/11/9
Background: Beta catenin plays a key role in cancer tumorigenesis. However, its prognostic significance in patients with colorectal cancer (CRC) remains controversial. It has been demonstrated that 90...
Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts,
flavonoids flavonols flavones flavanones flavan-3-ols anthocyanins colorectal cancer
2018/11/23
Background: Flavonoids inhibit the growth of colon cancer cells in vitro. In a secondary analysis of a randomized controlled trial, the Polyp Prevention Trial, a higher intake of one subclass, flavono...
Characteristics of the Patients With Colorectal Cancer:Epidemiologic Study or Pathology Report-Based Study
Colorectal Cancer Iran Colon Rectum Epidemiology Pathology
2015/10/16
In the Iranian Red Crescent Medical Journal issue published in June 2013, I read with great interest the article entitled “Frequency of all types of colorectal tumors in the patients referred to selec...
CORRELATING IRINOTECAN AND CAPECITABINE TREATMENT FOR COLORECTAL CANCER TO GENE EXPRESSION, POLYMORPHISMS, AND CLINICAL OUTCOMES
Irinotecan CPT-11 Capecitabine
2015/5/25
Colorectal cancer is the third most common type of cancer and the third most common cause of cancer-related mortality. There are three types of treatment available to patients, either individually or ...
Recent advances in anti-cancer treatment have seen improvements in survival for patients with metastatic colorectal cancer. Increasingly, patients with advanced disease are living longer, sometimes wi...
Colonoscopy has a central role in the detection and prevention of colorectal cancer. This is based on the fact that most colorectal cancer develops from premalignant adenomatous or serrated polyps, wh...
Surgery is the mainstay in the treatment of colorectal cancer. Considerable progress has been made in the past eight years since the publication of the most recent clinical practice guidelines for col...
Patients with resected colon cancer (stage III [T1 to T4, N1-N2] or high-risk stage II [T3 or T4, N0]) or stage II/III rectal cancers (T3 or T4, N0-2) are at significant risk of local and distant fail...
Targeting treatment for colorectal cancer: the EGFR antibody story
Targeting treatment colorectal cancer
2015/4/13
Frequent overexpression of the epidermal growth factor receptor in colorectal cancer was the rationale for the development of anti-epidermal growth factor receptor antibodies. The development of the d...
Risk profiling and surveillance: previous adenomas and colorectal cancer
previous adenomas colorectal cancer
2015/4/13
The brief of this issue of Cancer Forum is to review information available since the 2005 publication of the National Health and Medical Research Council relating to risk management of individuals wit...